SHIFT Team Intervention for Stroke
(SHIFT Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the SHIFT team intervention treatment for stroke?
Is the SHIFT Team Intervention for Stroke safe for humans?
How does the SHIFT Team Intervention treatment for stroke differ from other treatments?
The SHIFT Team Intervention for stroke is unique because it focuses on a coordinated team approach, using simulation-based training to improve the speed and effectiveness of acute stroke care. This method enhances team communication and process times, which is different from traditional treatments that may not emphasize team dynamics and training.1112131415
What is the purpose of this trial?
Primary Goal:To test the hypothesis that among stroke patients 18-75 years with ≥3 SDOH risk factors, SHIFT will improve: (1) functional outcomes as measured by the SIS (Primary Outcome), (2) physiological outcomes as measured by changes in blood pressure and cognition, (secondary outcomes) and (3) epigenetic allostatic load biomarkers (exploratory outcome) such as DNA methylation (DNAm) and telomere length, at 6 months and 1-year post-stroke, compared with usual care (UC).
Research Team
Richard T Benson, MD
Principal Investigator
NINDS Office of Global Health and Health Disparities
Eligibility Criteria
This trial is for African American and Hispanic stroke patients aged 18-75 who face at least three social determinants of health risks. It's not specified who can't join, but typically those with conditions that could interfere with the study or its results might be excluded.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
The SHIFT intervention team conducts home visits within 72 hours of hospital discharge to address SDOH barriers, provide counseling, and assist with medication management.
Follow-up
Participants are monitored for functional, physiological, and epigenetic outcomes at 6 months and 1 year post-stroke.
Treatment Details
Interventions
- SHIFT team intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Columbia University
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Collaborator